Kona Medical Inks $40M Series C

Kona Medical Inc. has closed its Series C round with the addition of $10 million in equity and debt, bringing total proceeds to $40 million. Investors include Essex Woodlands, Domain Associates, Morgenthaler Ventures, Western Technology Investments, and BioStar Ventures. Silicon Valley Bank provided the debt facility. Kona Medical is based in Bellevue, Washington, and Menlo Park, Calif. The company is developing ultrasound technology to treat the nerves leading to and from the kidney.

North AmericaUSBriefs